ISLAND PHARMACEUTICALS LIMITED

2.94%

16.5¢

Market Cap $42.02M

Healthcare Biotechnology

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Latest Threads

Tag

Subject

ILA

Ann: Completion of Galidesivir transaction

11:43

2.1K

11:43

Last post thechino

2.1K

ILA

Ann: Investor Presentation and investor roadshow

05:20

3.0K

05:20

Last post pinch2020

3.0K

ILA

Ann: Change of Director's Interest Notice - JC

25/07/25

2.0K

25/07/25

Last post cdoyle

2.0K

ILA

Ann: Portfolio expansion achieved with acquisition of Galidesivir

25/07/25

118

27K

25/07/25

Last post Beaza79

118

27K

ILA

Ann: Quarterly Appendix 4C and Activities Report

24/07/25

1.3K

24/07/25

Last post cdoyle

1.3K

ILA

ILA - Media coverage

23/07/25

31K

23/07/25

Last post Teeth

31K

ILA

Ann: Options exercise from existing substantial shareholder

23/07/25

6.9K

23/07/25

Last post TemujinOz

6.9K

ILA

Ann: Change in substantial holding

18/07/25

923

18/07/25

Last post IndexInvestor

923

See All Discussions

Timeline

Completion of Galidesivir transaction
31 Jul 08:22	Share

Investor Presentation and investor roadshow
28 Jul 13:22	Share

Change of Director's Interest Notice - JC
25 Jul 08:36	Share

Quarterly Appendix 4C and Activities Report
24 Jul 09:00	Share

Change in substantial holding
17 Jul 10:33	Share

Options exercise from existing substantial shareholder
17 Jul 10:32	Share

Cleansing Notice
16 Jul 08:29	Share

Application for quotation of securities - ILA
16 Jul 08:23	Share

Investor presentation
09 Jul 09:22	Share

Portfolio expansion achieved with acquisition of Galidesivir
09 Jul 09:16	Share

Trading Halt
07 Jul 09:33	Share

Notification of cessation of securities - ILA
04 Jul 09:00	Share

Cancel - Notification of cessation of securities - ILA
04 Jul 09:00	Share

Initial Director's Interest Notice
03 Jul 16:24	Share

Notification of cessation of securities - ILA
03 Jul 16:19	Share

Final Director's Interest Notice
03 Jul 16:18	Share

Appointment of Jason Carroll as Non-Executive Chairman
02 Jul 09:45	Share

Webinar presentation
17 Jun 08:46	Share

Successful Phase 2 clinical trial of ISLA-101
12 Jun 09:53	Share

Trading Halt
10 Jun 09:13	Share

Cleansing Notice
04 Jun 08:30	Share

Application for quotation of securities - ILA
04 Jun 08:27	Share

Change in substantial holding
03 Jun 13:06	Share

Change in substantial holding
02 Jun 07:31	Share

Change in substantial holding
29 May 14:10	Share

Cleansing Notice
29 May 08:52	Share

Application for quotation of securities - ILA
29 May 08:48	Share

Proposed issue of securities - ILA
21 May 09:09	Share

Proposed issue of securities - ILA
21 May 09:09	Share

Proposed issue of securities - ILA
21 May 09:08	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.5¢		Change -0.005(2.94%)		Mkt cap ! $42.02M

Open	High	Low	Value	Volume
17.0¢	17.0¢	16.0¢	$55.96K	342.7K

Buyers (Bids)

No.	Vol.	Price($)
2	124356	16.0¢

Sellers (Offers)

Price($)	Vol.	No.
16.5¢	14278	1

View Market Depth

No.	Vol.	Price($)
2	124356	0.160
3	48596	0.155
6	181106	0.150
4	121000	0.145
8	146211	0.140

Price($)	Vol.	No.
0.165	14278	1
0.170	128330	4
0.175	164181	5
0.180	107780	4
0.185	10000	1

Last trade - 11.21am 01/08/2025 (20 minute delay)


Last 17.0¢		Change -0.005 ( 3.03 %)
Open	High	Low	Volume
16.5¢	17.0¢	16.0¢	179813
Last updated 11.36am 01/08/2025 ?

ILA (ASX) Chart

ISLAND PHARMACEUTICALS LIMITED

Latest Threads

Redcastle Resources Delivers Positive Scoping Study for Queen Alexandra

Timeline

Featured News

Latest Videos

Island Pharmaceuticals (ASX:ILA) receives FDA feedback on clinical trial application

01 Feb 2023 15:53 (AEDT)

Latest Articles

Island enrols first subjects for Phase 2b clinical trial for dengue fever drug

Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test ISLA-101 as progress rolls on.

Island Pharma's anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happy

Island Pharma has reported witnessing anti-dengue 'activity' in Phase 2a readout results of its ISLA-101 drug.

Island Pharmaceuticals (ASX:ILA) receives $1.96m grant to support ISLA-101 clinical development

Island Pharmaceuticals (ASX:ILA) has received a $1.96 million grant to support phase 2a human clinical trials of its ISLA-101 dengue fever treatment.

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Featured News